The U.S. Food and Drug Administration clarified its rules around personal protective equipment (PPE) and its Emergency Use Authorizations regarding COVID-19.
As controversy heightens around potential treatments for COVID-19, government agencies and drug manufacturers are scrambling to find up-to-date information regarding authorized use.
Serological testing can elevate better data for public health practitioners as well as patient tracking to allow for the identification of who has been infected by COVID-19.